Immunological characterization of superantigen-induced intrauterine fetal and newborn death

Eriko Takei1, Hidekazu Tamauchi, Hiroko Maruyama

  • 1Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Kitasato 1-15-1, Sagamihara, Kanagawa 228-8555, Japan. eriko@med.kitasato-u.ac.jp

Abstract

Insights

Superantigen exposure during pregnancy, specifically toxic shock syndrome toxin-1 (TSST-1), increases fetal and newborn deaths. This is linked to elevated interleukin-2 (IL-2) and placental damage in susceptible mice.

Area of Science:

  • Immunology
  • Toxicology
  • Reproductive Biology

Background:

  • Superantigens, like TSST-1, can trigger potent immune responses.
  • Cytokine storms are associated with severe pathological outcomes.
  • Understanding maternal immune responses to toxins is crucial for fetal well-being.

Purpose of the Study:

  • To investigate the immunological and pathological effects of TSST-1 in pregnant mice.
  • To elucidate the role of T-cell receptor-transgenic (TCR-Tg) mice in modeling superantigen-induced toxicity.
  • To characterize the cytokine storm and its impact on pregnancy.

Main Methods:

  • TSST-1 was administered to pregnant mice with varying sensitivities.
  • Fetal/newborn death rates were recorded.
  • Serum cytokine levels (e.g., IL-2) and placental histology were analyzed.

Main Results:

  • TCR-Tg mice exhibited significantly higher fetal/newborn death rates after TSST-1 exposure.
  • Elevated serum IL-2 concentrations were observed in TCR-Tg mothers.
  • Placental examination revealed congestion and apoptosis in TCR-Tg mice.

Conclusions:

  • TSST-1 administration during pregnancy increases fetal/newborn mortality.
  • The observed increase in mortality is mediated by an IL-2-dependent immune pathway.
  • TCR-Tg mice serve as a valuable model for studying superantigen-induced pregnancy complications.